Excessive Daytime Sleepiness Market
Aug 21, 2019
FDA approves Non-Controlled treatment for Excessive Daytime Sleepiness
The U.S. Food and Drug Administration has approved WAKIX (pitolisant) to treat excessive daytime sleepiness (EDS) in adult patients with narcolepsy. The Narcolepsy therapy, developed by HARMONY therapeutics, is the first and the only treatment to get approval that is not labelled as a controlled substance by the US...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
